Overview
This webinar will provide the latest updates on the FDA Laboratory Developed Test (LDT) rule, including key developments in ongoing court cases and potential shifts under the new administration. Regardless of whether the rule is implemented, delayed, or overturned, maintaining a strong and strategic Quality Management System (QMS) is essential. Hear from leaders at Promega and McDermott Will & Emery as they discuss best practices to ensure your lab remains compliant, resilient, and prepared for any regulatory landscape, including:
- Current insights on legal and regulatory developments surrounding the FDA LDT rule
- How potential policy changes under the new administration may impact laboratory regulations
- Practical strategies to strengthen your Quality Management System and maintain compliance in any regulatory scenario